TY  - GEN
AU  - List,A F
AU  - Spier,C
AU  - Greer,J
AU  - Wolff,S
AU  - Hutter,J
AU  - Dorr,R
AU  - Salmon,S
AU  - Futscher,B
AU  - Baier,M
AU  - Dalton,W
TI  - Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia
SN  - 0732-183X
PY  - 1993///0923
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacokinetics
KW  - Carrier Proteins
KW  - genetics
KW  - Child
KW  - Child, Preschool
KW  - Cyclosporine
KW  - adverse effects
KW  - Daunorubicin
KW  - administration & dosage
KW  - Drug Resistance
KW  - Female
KW  - Gene Expression
KW  - Humans
KW  - Leukemia, Myeloid
KW  - blood
KW  - Male
KW  - Membrane Glycoproteins
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Phenotype
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1200/JCO.1993.11.9.1652
ER  -